Krystal Biotech, Inc. (KRYS)
NASDAQ·Healthcare·Biotechnology
$343.71
+6.29%
Mkt Cap $9.13B
Analyst Ratings
Buy
17
Hold
0
Sell
0
Price Target (12 analysts)
$311.00
Range $224.00 – $371.00
Implied Upside
-9.5%
Consensus $311.00 vs current $343.71
NASDAQ·Healthcare·Biotechnology
$343.71
+6.29%
Mkt Cap $9.13B
Buy
17
Hold
0
Sell
0
Price Target (12 analysts)
$311.00
Range $224.00 – $371.00
-9.5%
Consensus $311.00 vs current $343.71